RBC Capital Initiates Coverage On Sophia Genetics with Outperform Rating, Announces Price Target of $8
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has initiated coverage on Sophia Genetics with an Outperform rating and set a price target of $8. The company is listed on NASDAQ under the ticker SOPH.
November 29, 2023 | 10:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has initiated coverage on Sophia Genetics with an Outperform rating and a price target of $8, which could positively influence the stock's performance.
Analyst coverage, especially with an Outperform rating, typically signals confidence in a company's future performance and can lead to increased investor interest. The price target of $8 suggests a positive outlook for SOPH's stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100